NA Laboratory-Developed Tests (LDTs) Market - Industry Trends and Forecast to 2030
The North America Laboratory-Developed Tests (LDTs) Market is expected to reach USD 17,680.85 Million by 2030 from USD 6,901.04 Million in 2022, growing at a CAGR of 12.5% during the forecast period of 2023 to 2030.
Market Segmentation
North America Laboratory-Developed Tests (LDTs) Market, By Test Type (Clinical Chemistry and Immunology, Critical Care, Hematology, Molecular Diagnostics, Microbiology, and Other Test), Product Type (Consumables, Analyzers and Instruments, and Accessories), Sample Type (Blood, Urine, Tissue, Cerebrospinal Fluid (CSF), and Others), Therapeutic Area (Infections, Genetic Disorders, Oncology/Cancer, Autoimmune Disease, Urology, Gynecology, and Others), Gender (Male, and Female), Age Group (Geriatrics, Adult, and Pediatric), End Users (Hospital-Based Labs, Stand-Alone Labs, Diagnostic Chains, Academic Institutes, Clinical Research Organizations, Specialty Diagnostic Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors, and Others), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2030
Overview of North America Laboratory-Developed Tests (LDTs) Market Dynamics
Drivers
• Increasing demand for personalized medicines
• Advancements in molecular diagnostics
Restraint
• Stringent quality control and standardization for LDTs
Opportunity
• Increasing demand for precision medicine and targeted therapy
Market Players
Some of the major market players operating in the North America Laboratory-Developed Tests (LDTs) market are:
• F. Hoffmann-La Roche Ltd
• bioMérieux, Inc.
• Sysmex Corporation
• Biomerica, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott
• Siemens Medical Solutions USA, Inc.
• Quest Diagnostics Incorporated
• QIAGEN
• Eurofins Scientific
• Biodesix.
• Hologic, Inc.
• Guardant Health
• OPKO Health, Inc.
• BD
• Beckman Coulter, Inc.
• NeoGenomics Laboratories.
• Seegene Inc.
• Ambry Genetics
• BGI
• 23andMe, Inc.
• Admera Health
• Agendia
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The North America Laboratory-developed Tests (Ldts) Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Test Type Segment Lifeline Curve
- 2.8 Market End User Coverage Grid
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter's Five Forces Model
- 5 Industry Insights
- 6 Number Of Labs
- 6.1 Number Of Labs In Middle Eastern Countries
- 6.2 Number Of Labs In Europe
- 7 Regulations Of The North America Laboratory-developed Tests (Ldts) Market
- 7.1 U.S.
- 8 Market Overview
- 8.1 Drivers
- 8.1.1 Increasing Demand For Personalized Medicine
- 8.1.2 Advancements In Molecular Diagnostics
- 8.1.3 Growing Prevalence Of Chronic Diseases
- 8.1.4 Increasing Awareness And Acceptance Towards The Assistances Of Ldts
- 8.2 Restraints
- 8.2.1 Stringent Quality Control And Standardization For Ldts
- 8.2.2 Strict Regulatory Guidelines Regarding Ldts
- 8.3 Opportunities
- 8.3.1 Increasing Demand For Precision Medicine And Targeted Therapy
- 8.3.2 Enhanced Healthcare Substructure
- 8.4 Challenges
- 8.4.1 Deprived Data Interpretation And Integration
- 8.4.2 Complex Laboratory Processes
- 9 North America Laboratory-developed Tests (Ldts) Market, By Test Type
- 9.1 Overview
- 9.2 Clinical Chemistry And Immunology
- 9.2.1 Glucose
- 9.2.1.1 Glucose Challenge Test
- 9.2.1.2 Oral Glucose Tolerance Test (Ogtt)
- 9.2.2 Prothrombin
- 9.2.3 Metabolic Panel
- 9.2.3.1 Basic
- 9.2.3.2 Comprehensive
- 9.2.4 Lipid Panel
- 9.2.5 Liver Panel
- 9.2.5.1 Alp Test (Alkaline Phosphate)
- 9.2.5.2 Alt Test (Alkaline Transminase)
- 9.2.5.3 Ast Test (Aspartate Aminotransferase)
- 9.2.5.4 Gamma-glutamyl Transferase (Ggt) Test
- 9.2.6 Thyroid Stimulating Hormone
- 9.2.7 Urinalysis
- 9.2.7.1 Red Blood Cell Urine Test
- 9.2.7.2 Glucose Urine Test
- 9.2.7.3 Protein Urine Test
- 9.2.7.4 Urine Ph Level
- 9.2.7.5 Ketones Urine Test
- 9.2.7.6 Biliburin Urine Test
- 9.2.7.7 Urine Specific Gravity Test
- 9.2.8 Others
- 9.3 Critical Care
- 9.3.1 Carboxyhaemoglobin Test
- 9.3.2 Ph Test
- 9.3.3 Potassium Test
- 9.3.4 Sodium Test
- 9.3.5 Methemoglobin Test
- 9.3.6 Lactate Test
- 9.3.7 Others
- 9.4 Haematology
- 9.4.1 Complete Blood Count (Cbc)
- 9.4.1.1 White Blood Cell Count (Wbc)
- 9.4.1.2 Red Blood Cell Count (Rbc)
- 9.4.2 Platelet Count
- 9.4.3 Blood Protein Testing
- 9.4.4 Others
- 9.5 Molecular Diagnostic
- 9.5.1 Sample Type
- 9.5.1.1 Blood
- 9.5.1.2 Urine
- 9.5.1.3 Tissue
- 9.5.1.4 Cerebrospinal Fluid (Csf)
- 9.5.1.5 Others
- 9.5.2 Therapeutic Area
- 9.5.2.1 Infections
- 9.5.2.2 Genetic Disorders
- 9.5.2.3 Oncology/Cancer
- 9.5.2.4 Autoimmune Disease
- 9.5.2.5 Urology
- 9.5.2.6 Gynecology
- 9.5.2.7 Others
- 9.5.3 Technology
- 9.5.3.1 Polymerase Chain Reaction (Pcr)
- 9.5.3.2 Next-generation Sequencing (Ngs)
- 9.5.3.3 Fluorescence In Situ Hybridization (Fish)
- 9.5.3.4 Sanger Sequencing
- 9.5.3.5 Microarrays
- 9.5.3.6 Mass Spectrometry
- 9.5.3.7 Isothermal Amplification
- 9.5.4 End User
- 9.5.4.1 Hospital-based Labs
- 9.5.4.2 Stand-alone Labs
- 9.5.4.3 Diagnostic Chains
- 9.5.4.4 Academic Institutes
- 9.5.4.5 Clinical Research Organizations
- 9.5.4.6 Specialty Diagnostic Centers
- 9.5.4.7 Others
- 9.6 Microbiology
- 9.6.1 Microscopy
- 9.6.2 Culture
- 9.6.3 Antimicrobial Susceptibility Test
- 9.6.4 Others
- 9.7 Other Test
- 9.7.1 Drugs Of Abuse Testing
- 9.7.2 Hepatitis
- 9.7.3 Human Immunodeficiency Viruses (Hiv)
- 9.7.4 Malaria
- 9.7.5 Tuberculosis
- 9.7.6 Human Papillomavirus (Hpv)
- 9.7.7 Others
- 10 North America Laboratory-developed Tests (Ldts) Market, By Product Type
- 10.1 Overview
- 10.2 Consumables
- 10.2.1 Panels
- 10.2.2 Reagent And Kits
- 10.2.3 Others
- 10.3 Analyzers And Instruments
- 10.3.1 Fully-automated Instruments
- 10.3.2 Semi-automated Instruments
- 10.3.3 Others
- 10.4 Accessories
- 11 North America Laboratory-developed Tests (Ldts) Market, By Sample Type
- 11.1 Overview
- 11.2 Blood
- 11.3 Urine
- 11.4 Tissue
- 11.5 Cerebrospinal Fluid (Csf)
- 11.6 Others
- 12 North America Laboratory-developed Tests (Ldts) Market, By Therapeutic Area
- 12.1 Overview
- 12.2 Infections
- 12.2.1 Methicillin-resistant Staphylococcus Aureus (Mrsa)
- 12.2.2 Clostridium Difficile
- 12.2.3 Vancomycin-resistant Enterococci (Vre)
- 12.2.4 Carbapenem-resistant Bacteria
- 12.2.5 Flu
- 12.2.6 Respiratory Syncytial Virus (Rsv)
- 12.2.7 Candida
- 12.2.8 Tuberculosis And Drug-resistant Tba
- 12.2.9 Meningitis
- 12.2.10 Gastrointestinal Panel Testing
- 12.2.11 Chlamydia
- 12.2.12 Gonorrhea
- 12.2.13 Hiv
- 12.2.14 Hepatitis B
- 12.2.15 Hepatitis C
- 12.2.16 Other Infectious Diseases
- 12.3 Genetic Disorders
- 12.3.1 New Born Screening
- 12.3.2 Predictive And Presymptomatic Testing
- 12.3.3 Other Genetic Testing
- 12.4 Oncology/Cancer
- 12.4.1 Breast Cancer
- 12.4.2 Prostate Cancer
- 12.4.3 Colorectal Cancer
- 12.4.4 Cervical Cancer
- 12.4.5 Kidney Cancer
- 12.4.6 Liver Cancer
- 12.4.7 Blood Cancer
- 12.4.8 Lung Cancer
- 12.4.9 Other Cancer
- 12.5 Autoimmune Disease
- 12.6 Urology
- 12.7 Gynecology
- 12.8 Others
- 13 North America Laboratory-developed Tests (Ldts) Market, By Gender
- 13.1 Overview
- 13.2 Male
- 13.3 Female
- 14 North America Laboratory-developed Tests (Ldts) Market, By Age Group
- 14.1 Overview
- 14.2 Geriatrics
- 14.3 Adult
- 14.4 Pediatrics
- 15 North America Laboratory-developed Tests (Ldts) Market, By End User
- 15.1 Overview
- 15.2 Hospital-based Labs
- 15.3 Stand –alone Labs
- 15.4 Diagnostic Chains
- 15.5 Academic Institutes
- 15.6 Clinical Research Organistaion
- 15.7 Specialty Diagnostic
- 15.8 Others
- 16 North America Laboratory-developed Tests (Ldts) Market, By Distribution Channel
- 16.1 Overview
- 16.2 Direct Tender
- 16.3 Retail Sales
- 16.4 Third Party Distributors
- 16.5 Others
- 17 North America Laboratory-developed Tests (Ldts) Market, By Region
- 17.1 North America
- 17.1.1 U.S.
- 17.1.2 Canada
- 17.1.3 Mexico
- 18 North America Laboratory-developed Tests (Ldts) Market, Company Landscape
- 18.1 Company Share Analysis: North America
- 19 Company Profiles
- 19.1 F. Hoffmann-la Roche Ltd.
- 19.1.1 Company Snapshot
- 19.1.2 Revenue Analysis
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Development
- 19.2 Biomérieux
- 19.2.1 Company Snapshot
- 19.2.2 Revenue Analysis
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Developments
- 19.3 Sysmex Corporation
- 19.3.1 Company Snapshot
- 19.3.2 Revenue Analysis
- 19.3.3 Company Share Analysis
- 19.3.4 Product Portfolio
- 19.3.5 Recent Development
- 19.4 Biomerica.
- 19.4.1 Company Snapshot
- 19.4.2 Revenue Analysis
- 19.4.3 Company Share Analysis
- 19.4.4 Product Portfolio
- 19.4.5 Recent Development
- 19.5 Bio-rad Laboratories, Inc
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Development
- 19.6 23andme, Inc.
- 19.6.1 Company Snapshot
- 19.6.2 Revenue Analysis
- 19.6.3 Product Portfolio
- 19.6.4 Recent Developments
- List Of Tables
- Table 1 Number Of Genetic Testing Laboratories In Eu
- Table 2 North America Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 3 North America Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 4 North America Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 5 North America Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
- Table 6 North America Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 7 North America Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 8 North America Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 9 North America Critical Care In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 10 North America Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
- Table 11 North America Haematology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 12 North America Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)))
- Table 13 North America Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 14 North America Molecular Diagnostic In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 15 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 16 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 17 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
- Table 18 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
- Table 19 North America Microbiology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 20 North America Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
- Table 21 North America Other Test In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 22 North America Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 23 North America Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 24 North America Consumables In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 25 North America Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 26 North America Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 27 North America Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 28 North America Accessories In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 29 North America Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 30 North America Blood In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 31 North America Urine In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 32 North America Tissue In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 33 North America Cerebrospinal Fluid (Csf) In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 34 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 35 North America Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 36 North America Infections In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 37 North America Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 38 North America Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 39 North America Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 40 North America Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 41 North America Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 42 North America Autoimmune Disease In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 43 North America Urology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 44 North America Gynecology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 45 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 46 North America Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
- Table 47 North America Male In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 48 North America Female In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 49 North America Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
- Table 50 North America Geriatrics In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 51 North America Adult In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 52 North America Pediatrics In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 53 North America Laboratory-developed Tests (Ldts) Market, By End User, 2021-2030 (Usd Million)
- Table 54 North America Hospital-based Lab In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 55 North America Stand- Alone Labs In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 56 North America Diagnostic Chains In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 57 North America Academic Institutes In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 58 North America Clinical Research Organisation In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 59 North America Specialty Diagnostic In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 60 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 61 North America Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 62 North America Direct Tender In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 63 North America Retail Sales In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 64 North America Direct Tender In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 65 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
- Table 66 North America Laboratory-developed Tests (Ldts) Market, By Country, 2021-2030 (Usd Million)
- Table 67 North America Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 68 North America Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 69 North America Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 70 North America Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 71 North America Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 72 North America Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 73 North America Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 74 North America Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 75 North America Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 76 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 77 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 78 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
- Table 79 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
- Table 80 North America Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 81 North America Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 82 North America Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 83 North America Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 84 North America Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 85 North America Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 86 North America Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 87 North America Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 88 North America Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 89 North America Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 90 North America Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
- Table 91 North America Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
- Table 92 North America Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
- Table 93 North America Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 94 U.S. Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 95 U.S. Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 96 U.S. Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 97 U.S. Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 98 U.S. Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 99 U.S. Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 100 U.S. Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 101 U.S. Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 102 U.S. Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 103 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 104 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 105 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
- Table 106 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
- Table 107 U.S. Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 108 U.S. Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 109 U.S. Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 110 U.S. Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 111 U.S. Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 112 U.S. Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 113 U.S. Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 114 U.S. Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 115 U.S. Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 116 U.S. Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 117 U.S. Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
- Table 118 U.S. Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
- Table 119 U.S. Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
- Table 120 U.S. Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 121 Canada Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 122 Canada Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 123 Canada Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 124 Canada Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 125 Canada Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 126 Canada Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 127 Canada Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 128 Canada Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 129 Canada Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 130 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 131 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 132 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
- Table 133 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
- Table 134 Canada Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 135 Canada Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
- Table 136 Canada Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 137 Canada Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 138 Canada Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
- Table 139 Canada Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
- Table 140 Canada Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- Table 141 Canada Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 North America Laboratory-developed Tests (Ldts) Market: Segmentation
- Figure 2 North America Laboratory-developed Tests (Ldts) Market: Data Triangulation
- Figure 3 North America Laboratory-developed Tests (Ldts) Market: Droc Analysis
- Figure 4 North America Laboratory-developed Tests (Ldts) Market: North America Vs Regional Market Analysis
- Figure 5 North America Laboratory-developed Tests (Ldts) Market: Company Research Analysis
- Figure 6 North America Laboratory-developed Tests (Ldts) Market: Interview Demographics
- Figure 7 North America Laboratory-developed Tests (Ldts) Market: Market End User Coverage Grid
- Figure 8 North America Laboratory-developed Tests (Ldts) Market: Dbmr Market Position Grid
- Figure 9 North America Laboratory-developed Tests (Ldts) Market: Vendor Share Analysis
- Figure 10 North America Laboratory-developed Tests (Ldts) Market: Segmentation
- Figure 11 Rising Demand For Personalized Medicines And Advancements In Molecular Diagnostics Are Expected To Drive The Growth Of The North America Laboratory-developed Tests (Ldts) Market From 2023 To 2030
- Figure 12 The Clinical Chemistry And Immunology Segment Is Expected To Account For The Largest Share Of The North America Laboratory-developed Tests (Ldts) Market In 2023 & 2030
- Figure 13 Drivers, Restraints, Opportunities And Challenges Of The North America Laboratory-developed Tests (Ldts) Market
- Figure 14 North America Laboratory-developed Tests (Ldts) Market: By Test Type, 2022
- Figure 15 North America Laboratory-developed Tests (Ldts) Market: By Test Type, 2023-2030 (Usd Million)
- Figure 16 North America Laboratory-developed Tests (Ldts) Market: By Test Type, Cagr (2023-2030)
- Figure 17 North America Laboratory-developed Tests (Ldts) Market: By Test Type, Lifeline Curve
- Figure 18 North America Laboratory-developed Tests (Ldts) Market: By Product Type, 2022
- Figure 19 North America Laboratory-developed Tests (Ldts) Market: By Product Type, 2023-2030 (Usd Million)
- Figure 20 North America Laboratory-developed Tests (Ldts) Market: By Product Type, Cagr (2023-2030)
- Figure 21 North America Laboratory-developed Tests (Ldts) Market: By Product Type, Lifeline Curve
- Figure 22 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, 2022
- Figure 23 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, 2023-2030 (Usd Million)
- Figure 24 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, Cagr (2023-2030)
- Figure 25 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, Lifeline Curve
- Figure 26 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, 2022
- Figure 27 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, 2020-2029 (Usd Million)
- Figure 28 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, Cagr (2023-2030)
- Figure 29 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, Lifeline Curve
- Figure 30 North America Laboratory-developed Tests (Ldts) Market: By Gender, 2022
- Figure 31 North America Laboratory-developed Tests (Ldts) Market: By Gender, 2023-2030 (Usd Million)
- Figure 32 North America Laboratory-developed Tests (Ldts) Market: By Gender, Cagr (2023-2030)
- Figure 33 North America Laboratory-developed Tests (Ldts) Market: By Gender, Lifeline Curve
- Figure 34 North America Laboratory-developed Tests (Ldts) Market: By Age Group, 2022
- Figure 35 North America Laboratory-developed Tests (Ldts) Market: By Age Group, 2023-2030 (Usd Million)
- Figure 36 North America Laboratory-developed Tests (Ldts) Market: By Age Group, Cagr (2023-2030)
- Figure 37 North America Laboratory-developed Tests (Ldts) Market: By Age Group, Lifeline Curve
- Figure 38 North America Laboratory-developed Tests (Ldts) Market: By End User, 2022
- Figure 39 North America Laboratory-developed Tests (Ldts) Market: By End User, 2023-2030 (Usd Million)
- Figure 40 North America Laboratory-developed Tests (Ldts) Market: By End User, Cagr (2023-2030)
- Figure 41 North America Laboratory-developed Tests (Ldts) Market: By End User, Lifeline Curve
- Figure 42 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, 2022
- Figure 43 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 44 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, Cagr (2023-2030)
- Figure 45 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, Lifeline Curve
- Figure 46 North America Laboratory-developed Tests (Ldts) Market: Snapshot (2022)
- Figure 47 North America Laboratory-developed Tests (Ldts) Market: By Country (2022)
- Figure 48 North America Laboratory-developed Tests (Ldts) Market: By Country (2023 & 2030)
- Figure 49 North America Laboratory-developed Tests (Ldts) Market: By Country (2022 & 2030)
- Figure 50 North America Laboratory-developed Tests (Ldts) Market: By Test Type (2023-2030)
- Figure 51 North America Laboratory-developed Tests (Ldts) Market: Company Share 2022 (%) 184
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook